Adjuvant treatment suppresses IL-17 production by T cell-independent myeloid sources in nonobese diabetic mice

Molecular Immunology

Volumn 47, Issue 14, 2010, Pages 2397-2404

  Gao, Xiaogang ^a   Ding, Guoshan ^a   Wang, Zhengxin ^a   Fu, Hong ^a   Ni, Zhijia ^a   Ma, Jun ^a   Song, Shaohua ^a   Liu, Fang ^a   Fu, Zhiren ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adjuvant; IL 17; Myeloid cells; Type 1 diabetes

Indexed keywords

FREUND ADJUVANT; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL POPULATION; CYTOKINE PRODUCTION; DELTA T LYMPHOCYTE; DIABETES MELLITUS; GAMMA T LYMPHOCYTE; IMMUNIZATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE; TH17 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOIMMUNITY; CYTOKINES; DIABETES MELLITUS, TYPE 1; DOWN-REGULATION; FREUND'S ADJUVANT; IMMUNIZATION; INTERLEUKIN-17; INTERLEUKIN-23; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MYELOID CELLS; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS;

MUS;

EID: 77955417412     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.04.003     Document Type: Article

References (35)

1. Bending D., De La Peña H., Veldhoen M., Phillips T.M., Uyttenhove C., Stockinger B., Cooke A. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 2009, 119:565-572.
2. H17 and regulatory T cells. Nature 2006, 441:235-238.
3. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., kastelein R.A., Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
4. Goriely S., Goldman M. The interleukin-12 family: New players in transplantation immunity?. Am. J. Transplant. 2007, 7:278-284.
5. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
6. Jain R., Tartar D.M., Gregg R.K., Divekar R.D., Bell J.J., Lee H.H., Yu P., Ellis J.S., Hoeman C.M., Franklin C.L., Zaghouani H. Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J. Exp. Med. 2008, 205:207-218.
7. King C., Ilic A., Koelsch K., Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004, 117:265-277.
8. Lee I.F., Qin H., Priatel J.J., Tan R. Critical role for IFN-γ in natural killer cell-mediated protection from diabetes. Eur. J. Immunol. 2008, 38:82-89.
9. Liu S.J., Tsai J.P., Shen C.R., Sher Y.P., Hsieh C.L., Yeh Y.C., Chou A.H., Chang S.R., Hsiao K.N., Yu F.W., Chen H.W. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-β and interleukin-6. J. Leukoc. Biol. 2007, 82:354-360.
10. Lockhart E., Green A.M., Flynn J.L. IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 2006, 177:4662-4669.
11. Mangan P.R., Harrington L.E., O'Quin D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-β induces development of the Th17 lineage. Nature 2006, 441:231-234.
12. Manirarora J.N., Kosiewicz M.M., Parnell S.A., Alard P. APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development. PLoS One 2008, 3:e3739.
13. Martin-Orozco N., Chung Y., Chang S.H., Wang Y.H., Dong C. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 2009, 39:216-224.
14. McInerney M.F., Pek S.B., Thomas D.W. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 1991, 40:715-725.
15. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., Seggwick J.D., Cua D.J. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003, 198:1951-1957.
16. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
17. Qin H.Y., Singh B. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J. Autoimmun. 1997, 10:271-278.
18. Qin H.Y., Sadelain M.W., Hitchon C., Lauzon J., Singh B. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol. 1993, 150:2072-2080.
19. Qin H.Y., Elliott J.F., Lakey J.R., Rajotte R.V., Singh B. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy. J. Autoimmun. 1998, 11:591-601.
20. Qin H.Y., Chaturvedi P., Singh B. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-γ/TNF-α. Int. Immunol. 2004, 16:1723-1732.
21. Ryu S., Kodama S., Ryu K., Schoenfeld D.A., Faustman D.L. Reversal of established autoimmune diabetes by restoration of endogenous β cell function. J. Clin. Invest. 2001, 108:63-72.
22. Sadelain M.W., Qin H.Y., Lauzon J., Singh B. Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 1990, 39:583-589.
23. Song C., Luo L., Lei Z., Li B., Liang Z., Liu G., Li D., Zhang G., Huang B., Feng Z.H. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J. Immunol. 2008, 181:6117-6124.
24. Spolski R., Kashyap M., Robinson C., Yu Z., Leonard W.J. IL-21 signaling is critical for the development of type 1 diabetes in the NOD mice. Proc. Natl. Acad. Sci. USA. 2008, 105:14028-14033.
25. Stefan Y., Meda P., Neufeld M., Orci L. Stimulation of insulin secretion reveals heterogeneity of pancreatic B cells in vivo. J. Clin. Invest. 1987, 80:175-183.
26. Stritesky G.L., Yeh N., Kaplan M.H. IL-23 promotes maintenance but not commitment to the Th17 lineage. J. Immunol. 2008, 181:5948-5955.
27. Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996, 85:291-297.
28. Tisch R., Wang B., Serreze D.V. Induction of GAD65-specific Th2 cells and suppression of autoimmune diabetes at the late stages of disease is epitope-dependent. J. Immunol. 1999, 163:1178-1187.
29. Uhlig H.H., McKenzie B.S., Hue S., Thompson C., Joyce-Shaikh B., Stepankova R., Robinson N., Buonocore S., Tlaskalova-Hogenova H., Cua D.J., Powrie F. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006, 25:309-318.
30. Umemura M., Yahagi A., Hamada S., Begum M.D., Watanabe H., Kawakami K., Suda T., Sudo K., Nakae S., Iwakura Y., Matsuzaki G. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacilli Calmette-Guerin infection. J. Immunol. 2007, 178:3786-3796.
31. Van Y.H., Lee W.H., Ortiz S., Lee M.H., Qin H.J., Liu C.P. All-trans retinoic acids inhibits type 1 diabetes by Treg-dependent suppression of IFN-γ-producing-T-cells without affecting Th17 cells. Diabetes 2009, 58:146-155.
32. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
33. Vukkadapu S.S., Belli J.M., Ishii K., Jegga A.G., Hutton J.J., Aronow B.J., Katz J.D. Dynamic interaction between T cell-mediated β-cell damage and β-cell repair in the run up to autoimmune diabetes of the NOD mice. Physiol. Genomics 2005, 21:201-211.
34. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Ann. Rev. Immunol. 2007, 25:821-852.
35. Yu J.J., Gaffen S.L. Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front. Biosci. 2008, 13:170-177.